AQUAPed: Validation Study of AQUA© Questionnaire Modified for Childhood
NCT03286894 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1264
Last updated 2018-10-24
Summary
The AQUA© questionnaire developed in 2008 is a validated tools for the screening of allergic diseases in adult athletes. The objective of the present study is to develop and validate a modified version of the AQUA© questionnaire to be used in childhood. In this phase, the validation is intended to assess the reliability of the information collected through the AQUA© modified version: question difficulty and response patterns with respect to children characteristics (in particular age, sex and physical activity). In particular, the focus will be on the "core questions", i.e. the indicators of allergic disorders. This is a cross-sectional study on 1264 healthy schoolchildren aged 8 to 14 years.
Conditions
- Healthy
Sponsors & Collaborators
-
Istituto per la Ricerca e l'Innovazione Biomedica
lead OTHER
Eligibility
- Min Age
- 8 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-01
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Pertussis Immunisation and Food Allergy
NCT02490007 ·Status: COMPLETED
-
Effectiveness of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects
NCT00729508 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis
NCT01383590 ·Status: COMPLETED ·Phase: PHASE1
-
The 3rd COPENHAGEN Puberty Study
NCT04884620 ·Status: RECRUITING
-
Identification of Potential Biomarkers of Peptide Immunotherapy. Part 2 - Gene Array Analysis
NCT01383603 ·Status: COMPLETED ·Phase: PHASE1
-
Safety of Cat-PAD to Treat Cat Allergy in Cat Allergic Subjects With Controlled Asthma
NCT00867906 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
NCT00004800 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003
NCT01661751 ·Status: COMPLETED ·Phase: PHASE3
-
Allergy and COVID-19 Vaccines
NCT05028257 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT01057888 ·Status: COMPLETED ·Phase: NA
-
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 ·Status: COMPLETED ·Phase: NA
-
Impact of Vaccination on Th2 Immunity in Infancy
NCT02213341 ·Status: TERMINATED
-
Pertussis Vaccine in Healthy Pregnant Women
NCT00707148 ·Status: COMPLETED ·Phase: PHASE1
-
An Optional Two Year Follow Up Study to Study CP005A
NCT01604018 ·Status: COMPLETED
-
Immunization Schedule Alert Platform
NCT03705455 ·Status: UNKNOWN ·Phase: NA
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine
NCT07203755 ·Status: RECRUITING ·Phase: PHASE1
-
Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine
NCT00258882 ·Status: COMPLETED
-
Immunogenicity and Safety of the Concomitant Administration of a Tdap Vaccine and Meningococcal ACWY Conjugate Vaccine in Healthy Subjects Aged 11-25 Years
NCT00329901 ·Status: COMPLETED ·Phase: PHASE3
-
Cat-PAD Follow on Study
NCT01272323 ·Status: COMPLETED
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
NCT01689324 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)
NCT04051268 ·Status: COMPLETED ·Phase: PHASE3
-
Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy Adults
NCT00928785 ·Status: COMPLETED ·Phase: PHASE3
-
Text Message Vaccine Reminders for Adolescents With Chronic Medical Conditions
NCT02231957 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA